Table 3. Differentially expressed miRNAs in the validation set determined using qRT-PCR (containing samples used in the selection phase).
Gene symbol | Rank | Parametric P-value | HCs (n = 70) | RA (n = 75) | Fold-change | |
---|---|---|---|---|---|---|
Up-regulated | hsa-miR-4634 | 1 | 0.0118 | 10.01 | 4.358 | 2.297 |
hsa-miR-181d | 2 | 0.0201 | 4.060 | 1.686 | 2.408 | |
hsa-miR-4764-5 p | 3 | 0.0299 | 15.12 | 29.69 | 1.964 | |
Down-regulated | hsa-miR-342-3p | 1 | 0.0001 | 2.310 | 0.5078 | 0.2198 |
hsa-miR-3926 | 2 | 0.0001 | 6.891 | 1.182 | 0.1715 | |
hsa-miR-3925-3p | 3 | 0.0001 | 0.8896 | 0.04146 | 0.04661 | |
hsa-miR-122-3p | 4 | 0.0207 | 13.27 | 2.729 | 0.2057 | |
hsa-miR-9-5p | 5 | 0.0223 | 7.625 | 21.32 | 0.2796 | |
hsa-miR-219-2-3p | 6 | 0.0331 | 16.18 | 3.768 | 0.2329 |
Ranked by P-values generated from statistical comparisons between RA patients and HCs. In the RA and HCs columns, values for the mean of 2−Δcq for each group are listed. Fold-change is the ratio of relative expression of RA vs. HCs.